Author | Judith Becker, MD

Articles

Cardiovascular risk in ADHD pharmacotherapy

November 01, 2009

Pharmacotherapy, namely the stimulant medications methylphenidate (MPH) and amphetamine (MAS) and the nonstimulant medication atomoxetine (Strattera), is the recommended treatment for attention-deficit/hyperactivity disorder (ADHD).